Isocombretastatins a versus combretastatins a: the forgotten isoCA-4 isomer as a highly promising cytotoxic and antitubulin agent

J Med Chem. 2009 Jul 23;52(14):4538-42. doi: 10.1021/jm900321u.

Abstract

Herein is reported a convergent synthesis of isocombretastatins A, a novel class of potent antitubulin agents. These compounds having a 1,1-diarylethylene scaffold constitute the simplest isomers of natural Z-combretastatins A that are easy to synthesize without need to control the Z-olefin geometry. The discovery of isoCA-4 with biological activities comparable to that of CA-4 represents a major progress in this field.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Bibenzyls / chemistry*
  • Bibenzyls / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Chlorophenols / chemistry*
  • Chlorophenols / pharmacology*
  • Humans
  • Models, Molecular
  • Molecular Conformation
  • Peptides, Cyclic / chemistry*
  • Peptides, Cyclic / pharmacology*
  • Stereoisomerism
  • Tubulin Modulators / chemistry*
  • Tubulin Modulators / pharmacology*

Substances

  • Antineoplastic Agents
  • Bibenzyls
  • Chlorophenols
  • Peptides, Cyclic
  • Tubulin Modulators
  • complestatin
  • combretastatin